These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo. Roger P, Auclair J, Drain P. J Diabetes Complications; 1999 Sep; 13(2):62-7. PubMed ID: 10432168 [Abstract] [Full Text] [Related]
10. A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin. McNulty SJ, Ur E, Williams G, Multicenter Sibutramine Study Group. Diabetes Care; 2003 Jan; 26(1):125-31. PubMed ID: 12502668 [Abstract] [Full Text] [Related]
11. Dexfenfluramine in type II diabetes: effect on weight and diabetes control. Stewart GO, Stein GR, Davis TM, Findlater P. Med J Aust; 1993 Feb 01; 158(3):167-9. PubMed ID: 8450782 [Abstract] [Full Text] [Related]
17. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone. Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF. Metabolism; 2008 Nov 01; 57(11):1552-7. PubMed ID: 18940393 [Abstract] [Full Text] [Related]
20. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors. Swinburn BA, Carmichael HE, Wilson MR. Int J Obes Relat Metab Disord; 1996 Nov 01; 20(11):1033-40. PubMed ID: 8923161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]